Lexicon Pharmaceuticals Inc (LXRX)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -25.022 | -28.295 | -33.454 | 37.083 | -18.849 | -51.517 | -61.559 | -83.6 |
Return on Equity (%) | -63.814 | -123.196 | -938.226 | 286.965 | -42.837 | -65.014 | -88.371 | -168.497 |
Return on Invested Capital (%) | -43.649 | -51.463 | -40.555 | 60.472 | -70.437 | -64.519 | -72.152 | -96.086 |
Operating Margin (%) | -161.827 | -149.142 | -157.843 | 44.957 | -183.497 | -29179.866 | -71341.007 | -13622.757 |
Net Profit Margin (%) | -169.707 | -142.857 | -190.713 | 40.405 | -244.109 | -29448.993 | -73341.007 | -14710.88 |
Book Value Per Share | 0.571 | -0.42 | -1.143 | 0.497 | 0.79 | 0.464 | 0.385 | 0.198 |
Earnings Per Share | -1.356 | -1.222 | -1.138 | 1.225 | -0.414 | -0.589 | -0.54 | -0.723 |
Cash Per Share | 0.447 | 0.584 | 0.759 | 0.34 | 0.892 | 0.43 | 0.246 | 0.092 |
Working Capital Per Share | 1.853 | 1.874 | 1.289 | 2.563 | 0.784 | 0.449 | 0.624 | 0.592 |
Operating Profit Per Share | 0.806 | 0.852 | 0.59 | 3.017 | 0.156 | 0.002 | 0.001 | 0.005 |
EBIT Per Share | -1.356 | -1.342 | -1.138 | 1.168 | -0.414 | -0.589 | -0.54 | -0.723 |
EBITDA Per Share | -1.356 | -1.342 | -1.138 | 1.168 | -0.414 | -0.589 | -0.54 | -0.723 |
Free Cash Flow Per Share | -1.374 | -1.252 | -1.172 | 1.191 | -0.434 | -0.583 | -0.535 | -0.723 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 104,28M | 105,59M | 105,93M | 106,27M | 141,5M | 148,92M | 188,73M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 188,73M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | -125470.833 | N/A | N/A | N/A | -3845.044 | N/A | N/A |
Net Profit Margin (%) | N/A | -133058.333 | N/A | N/A | N/A | -4282.92 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 266,96M |
Ratio cours/bénéfice | -1,59 |
Ratio prix/ventes | 236,36 |
Ratio prix/liquidités | 12,56 |
Ratio prix/valeur comptable | 3,03 |
Rendement de dividende | - |
Actions en circulation | 361,49M |
Volume moyen (1 semaine) | 2,94M |
Volume moyen (1 mois) | 5,53M |
Variation sur 52 semaines | -47,68% |
Plus haut sur 52 semaines | 3,73 |
Plus bas sur 52 semaines | 0,6204 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales